(Q33837274)

29 July 2017

1 reference

title

The impact of patient treatment preferences on the interpretation of randomised controlled trials (English)

1 reference

29 July 2017

1 reference

McPherson K

1

1 reference

PubMed ID

10673968

29 July 2017

Britton A

series ordinal

2

1 reference

29 July 2017

1 October 1999

1 reference

European Journal of Cancer

29 July 2017

1 reference

29 July 2017

35

1 reference

29 July 2017

11

1 reference

29 July 2017

1598-1602

1 reference

Effect of psychosocial treatment on survival of patients with metastatic breast cancer

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900196-3

7 January 2021

Psychological response to cancer and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900196-3

7 January 2021

Psychosocial correlates of survival in advanced malignant disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900196-3

7 January 2021

Harnessing placebo effects in health care

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900196-3

7 January 2021

Placebo effect in double-blind clinical trials: a review of interactions with medications

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900196-3

7 January 2021

Psychology and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900196-3

7 January 2021

Are randomized controlled trials controlled? Patient preferences and unblind trials

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900196-3

7 January 2021

Physiologic and psychobehavioral research in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900196-3

7 January 2021

Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900196-3

7 January 2021

Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancer. 'Nolvadex' Adjuvant Trial Organisation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900196-3

7 January 2021

West Midlands Oncology Association trials of adjuvant chemotherapy in operable breast cancer: results after a median follow-up of 7 years. I. Patients with involved axillary lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900196-3

7 January 2021

The Northwick Park electroconvulsive therapy trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900196-3

7 January 2021

What is the prior probability of a proposed new treatment being superior to established treatments?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900196-3

7 January 2021

A two-stage trial design for testing treatment, self-selection and treatment preference effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900196-3

7 January 2021

Patient Preferences in Randomised Trials: Threat or Opportunity?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900196-3

7 January 2021

Comparison of chorionic villus sampling and amniocentesis for fetal karyotyping at 10-13 weeks' gestation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900196-3

7 January 2021

10.1016/S0959-8049(99)00196-3

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10673968